| Literature DB >> 25478565 |
Hyun-Jeong Lee1, Hye-Sun Park2, Woonsu Kim2, Duhak Yoon3, Seongwon Seo2.
Abstract
The interrelationship between muscle and adipose tissues plays a major role in determining the quality of carcass traits. The objective of this study was to compare metabolic differences between muscle and intramuscular adipose (IMA) tissues in the longissimus dorsi (LD) of Hanwoo (Bos taurus coreanae) using the RNA-seq technology and a systems biology approach. The LD sections between the 6th and 7th ribs were removed from nine (each of three cows, steers, and bulls) Hanwoo beef cattle (carcass weight of 430.2 ± 40.66 kg) immediately after slaughter. The total mRNA from muscle, IMA, and subcutaneous adipose and omental adipose tissues were isolated and sequenced. The reads that passed quality control were mapped onto the bovine reference genome (build bosTau6), and differentially expressed genes across tissues were identified. The KEGG pathway enrichment tests revealed the opposite direction of metabolic regulation between muscle and IMA. Metabolic gene network analysis clearly indicated that oxidative metabolism was upregulated in muscle and downregulated in IMA. Interestingly, pathways for regulating cell adhesion, structure, and integrity and chemokine signaling pathway were upregulated in IMA and downregulated in muscle. It is thus inferred that IMA may play an important role in the regulation of development and structure of the LD tissues and muscle/adipose communication.Entities:
Year: 2014 PMID: 25478565 PMCID: PMC4247929 DOI: 10.1155/2014/679437
Source DB: PubMed Journal: Int J Genomics ISSN: 2314-436X Impact factor: 2.326
Figure 1Transcriptomic profiles and clustering of differentially expressed genes (DEG) among four different tissues and three sexes in Hanwoo. The tissues were muscle (MUS), intramuscular adipose (IMA), subcutaneous adipose (SUA), and omental adipose (OMA), and the sexes were cow (C), bull (B), and steer (S). (a) Heat map of levels of gene expressions and hierarchical clustering and (b) clustering using principle component analysis of DEG.
List of oppositely up- or downregulated KEGG pathways in the longissimus dorsi intramuscular adipose tissue compared to muscle and subcutaneous adipose and omental adipose tissues in Hanwoo.
| KEGG ID | Pathway | Fold enrichment | Bonferroni | |
|---|---|---|---|---|
| Upregulated | bta04510 | Focal adhesion† | 2.7 | 7.0 |
| bta04512 | ECM-receptor interaction† | 3.7 | 8.2 | |
| bta04360 | Axon guidance† | 2.8 | 1.5 | |
| bta05200 | Pathways in cancer | 1.8 | 1.6 | |
| bta04270 | Vascular smooth muscle contraction | 2.4 | 3.7 | |
| bta04062 | Chemokine signaling pathway† | 2.0 | 9.9 | |
| bta05412 | Arrhythmogenic right ventricular cardiomyopathy | 2.8 | 1.3 | |
| bta04810 | Regulation of actin cytoskeleton† | 1.9 | 1.9 | |
| bta05414 | Dilated cardiomyopathy | 2.5 | 4.2 | |
|
| ||||
| Downregulated | bta00190 | Oxidative phosphorylation‡ | 6.2 | 2.4 |
| bta05012 | Parkinson's disease‡ | 6.0 | 7.9 | |
| bta05016 | Huntington's disease‡ | 4.8 | 7.5 | |
| bta05010 | Alzheimer's disease‡ | 4.8 | 8.4 | |
| bta00020 | Citrate cycle (TCA cycle)‡ | 10.5 | 4.9 | |
| bta03050 | Proteasome‡ | 7.0 | 1.4 | |
| bta00280 | Valine, leucine, and isoleucine degradation | 5.9 | 1.2 | |
| bta00640 | Propanoate metabolism | 6.7 | 8.8 | |
| bta00071 | Fatty acid degradation | 5.4 | 8.7 | |
| bta00650 | Butanoate metabolism | 5.4 | 8.1 | |
| bta00620 | Pyruvate metabolism‡ | 4.7 | 2.7 | |
†Downregulated in the muscle tissue.
‡Upregulated in the muscle tissue.
List of oppositely up- or downregulated KEGG pathways in the longissimus dorsi muscle tissue compared to intramuscular, subcutaneous, and omental adipose tissues in Hanwoo.
| KEGG ID | Pathway | Fold enrichment | Bonferroni | |
|---|---|---|---|---|
| Upregulated | bta05012 | Parkinson's disease† | 4.2 | 1.4 |
| bta05010 | Alzheimer's disease† | 3.7 | 5.3 | |
| bta00190 | Oxidative phosphorylation† | 4.0 | 8.3 | |
| bta05016 | Huntington's disease† | 3.4 | 2.2 | |
| bta03050 | Proteasome† | 5.3 | 9.5 | |
| bta04260 | Cardiac muscle contraction | 3.7 | 3.2 | |
| bta00020 | Citrate cycle (TCA cycle)† | 5.1 | 8.7 | |
| bta05410 | Hypertrophic cardiomyopathy (HCM) | 2.7 | 4.9 | |
| bta05414 | Dilated cardiomyopathy | 2.5 | 1.9 | |
| bta00230 | Purine metabolism | 2.0 | 2.8 | |
| bta04120 | Ubiquitin mediated proteolysis | 2.1 | 3.2 | |
| bta00620 | Pyruvate metabolism† | 3.0 | 2.7 | |
| bta00010 | Glycolysis/gluconeogenesis | 2.6 | 2.9 | |
|
| ||||
| Downregulated | bta04510 | Focal adhesion‡ | 1.9 | 1.3 |
| bta04512 | ECM-receptor interaction‡ | 2.4 | 5.0 | |
| bta04640 | Hematopoietic cell lineage | 2.3 | 1.9 | |
| bta04062 | Chemokine signaling pathway‡ | 1.8 | 4.7 | |
| bta04360 | Axon guidance‡ | 2.0 | 7.5 | |
| bta04670 | Leukocyte transendothelial migration | 2.0 | 1.1 | |
| bta04060 | Cytokine-cytokine receptor interaction | 1.7 | 6.3 | |
| bta00600 | Sphingolipid metabolism | 2.7 | 3.7 | |
| bta04514 | Cell adhesion molecules (CAMs) | 1.8 | 4.2 | |
| bta04810 | Regulation of actin cytoskeleton‡ | 1.6 | 5.9 | |
| bta04142 | Lysosome | 1.8 | 6.6 | |
| bta04666 | Fc gamma R-mediated phagocytosis | 2.0 | 8.6 | |
†Downregulated in the intramuscular adipose tissue.
‡Upregulated in the intramuscular adipose tissue.